» Articles » PMID: 35547918

An Efficient One-pot Conversion of Carboxylic Acids into Benzimidazoles an HBTU-promoted Methodology

Overview
Journal RSC Adv
Specialty Chemistry
Date 2022 May 13
PMID 35547918
Authors
Affiliations
Soon will be listed here.
Abstract

Benzimidazole is a privileged, and routinely used pharmacophore in the drug discovery process. Herein, we report a mild, acid-free and one-pot synthesis of indole, alkyl and alpha-amino benzimidazoles through a novel HBTU-promoted methodology. An extensive library of indole-carboxylic acids, alkyl carboxylic acids and -protected alpha-amino acids has been converted into the corresponding benzimidazoles in 80-99% yield. Since alpha-aminobenzimidazoles are highly useful synthons as chiral ligands for chemical catalysis, as well as for drug discovery endeavors, our reported method provides direct access to this scaffold in a simple, one-pot operation from commercially available carboxylic acids.

Citing Articles

A Green one-pot three component synthesis of thiazolidine-2,4-dione based bisspirooxindolo-pyrrolidines with [Bmim]BF: their in vitro and in silico anti-TB studies.

Rukyanaik V, Gamidi R, Kumari J, Sriram D, Basavoju S Mol Divers. 2024; 29(1):303-317.

PMID: 38789853 DOI: 10.1007/s11030-024-10853-5.


Discovery of a novel class of benzimidazoles as highly effective agonists of bone morphogenetic protein (BMP) receptor signaling.

Najafi S, Barasa L, Huang S, Yoganathan S, Perron J Sci Rep. 2022; 12(1):12146.

PMID: 35840622 PMC: 9287337. DOI: 10.1038/s41598-022-16394-x.


Design and Synthesis of Poly(ADP-ribose) Polymerase Inhibitors: Impact of Adenosine Pocket-Binding Motif Appendage to the 3-Oxo-2,3-dihydrobenzofuran-7-carboxamide on Potency and Selectivity.

Velagapudi U, Langelier M, Delgado-Martin C, Diolaiti M, Bakker S, Ashworth A J Med Chem. 2019; 62(11):5330-5357.

PMID: 31042381 PMC: 7378964. DOI: 10.1021/acs.jmedchem.8b01709.

References
1.
Hoyt S, Park M, London C, Xiong Y, Tata J, Bennett D . Discovery of Benzimidazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys. ACS Med Chem Lett. 2015; 6(5):573-8. PMC: 4434468. DOI: 10.1021/acsmedchemlett.5b00054. View

2.
Shin Y, Suchomel J, Cardozo M, Duquette J, He X, Henne K . Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors. J Med Chem. 2015; 59(1):431-47. DOI: 10.1021/acs.jmedchem.5b01651. View

3.
Zhang H, Damu G, Cai G, Zhou C . Design, synthesis and antimicrobial evaluation of novel benzimidazole type of Fluconazole analogues and their synergistic effects with Chloromycin, Norfloxacin and Fluconazole. Eur J Med Chem. 2013; 64:329-44. DOI: 10.1016/j.ejmech.2013.03.049. View

4.
Singh S, Prasad N, Chufan E, Patel B, Wang Y, Chen Z . Design and synthesis of human ABCB1 (P-glycoprotein) inhibitors by peptide coupling of diverse chemical scaffolds on carboxyl and amino termini of (S)-valine-derived thiazole amino acid. J Med Chem. 2014; 57(10):4058-72. PMC: 4032198. DOI: 10.1021/jm401966m. View

5.
Lai T, Xie D, Zhou C, Cai G . Copper-Catalyzed Inter/Intramolecular N-Alkenylation of Benzimidazoles via Tandem Processes Involving Selectively Mild Iodination of sp C-H Bond at α-Position of Ester. J Org Chem. 2016; 81(19):8806-8815. DOI: 10.1021/acs.joc.6b01465. View